ICU Medical, Inc. (ICUI): Price and Financial Metrics


ICU Medical, Inc. (ICUI)

Today's Latest Price: $188.97 USD

0.27 (0.14%)

Updated Dec 1 6:55pm

Add ICUI to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 143 in Medical - Devices & Equipment

See all "A" rated Strong Buy stocks

ICUI Stock Summary

  • For ICUI, its debt to operating expenses ratio is greater than that reported by just 0.51% of US equities we're observing.
  • With a year-over-year growth in debt of -100%, Icu Medical Inc's debt growth rate surpasses only 0% of about US stocks.
  • In terms of volatility of its share price, ICUI is more volatile than just 2.3% of stocks we're observing.
  • If you're looking for stocks that are quantitatively similar to Icu Medical Inc, a group of peers worth examining would be GMED, TRUE, SPSC, SSTK, and PLPC.
  • ICUI's SEC filings can be seen here. And to visit Icu Medical Inc's official web site, go to www.icumed.com.

ICUI Stock Price Chart Interactive Chart >

Price chart for ICUI

ICUI Price/Volume Stats

Current price $188.97 52-week high $236.51
Prev. close $188.70 52-week low $158.01
Day low $188.00 Volume 105,800
Day high $191.02 Avg. volume 152,239
50-day MA $188.69 Dividend yield N/A
200-day MA $192.10 Market Cap 3.96B

ICU Medical, Inc. (ICUI) Company Bio


ICU Medical develops, manufactures, and sells medical devices used in infusion therapy, oncology, and critical care applications worldwide. The company was founded in 1984 and is based in San Clemente, California.

ICUI Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$188.97$71.58 -61%

The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for Icu Medical Inc. To summarize, we found that Icu Medical Inc ranked in the 26th percentile in terms of potential gain offered. We should note, though, that the most conservative analysis suggests this stock will yield negative results -- and thus may be a potential short opportunity. In terms of the factors that were most noteworthy in this DCF analysis for ICUI, they are:

  • The stock's equity weight, or the proportion of capital from equity relative to debt, is 100. Its equity weight surpasses that of 95.79% of free cash flow generating stocks in the Healthcare sector.
  • The business' balance sheet suggests that 0% of the company's capital is sourced from debt; this is greater than merely 0.05% of the free cash flow producing stocks we're observing.
  • ICUI's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 2%; for context, that number is higher than 55.86% of tickers in our DCF set.


Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price
0%-62%
1%-62%
2%-61%
3%-61%
4%-61%
5%-60%

ENTA, WAT, ILMN, XRAY, and A can be thought of as valuation peers to ICUI, in the sense that they are in the Healthcare sector and have a similar price forecast based on DCF valuation.


ICUI Latest News Stream


Event/Time News Detail
Loading, please wait...

ICUI Latest Social Stream


Loading social stream, please wait...

View Full ICUI Social Stream

Latest ICUI News From Around the Web

Below are the latest news stories about Icu Medical Inc that investors may wish to consider to help them evaluate ICUI as an investment opportunity.

ICU Medical, Inc. 2020 Q2 - Results - Earnings Call Presentation

The following slide deck was published by ICU Medical, Inc. in conjunction with their 2020 Q2 earnings call....

SA Transcripts on Seeking Alpha | August 11, 2020

ICU Medical inks distribution agreement with Grifols for IV solution products

ICU Medical (ICUI) has entered into a long-term agreement with Grifols to distribute non-PVC/non-DEHP IV containers for 0.9% Sodium Chloride Injection, USP in the U.S.The new agreement will expand ICU Medical's non-PVC/non-DEHP offering to include 50 mL to 1000 mL container sizes; additionally, the company plans to distribute Grifols' Dextrose IV solutions...

Seeking Alpha | August 10, 2020

ICU Medical Broadens its Non-PVC/Non-DEHP IV Solutions Portfolio by Entering Long-Term U.S. Distribution Agreement with Grifols for Certain Core IV Solution Products

SAN CLEMENTE, Calif., Aug. 10, 2020 /PRNewswire/ -- ICU Medical Inc. (NASDAQ: ICUI) today announced that it has entered into a long-term agreement with Grifols to distribute a full line of non-PVC/non-DEHP IV containers for 0.9% Sodium Chloride Injection, USP to customers in the United…

PR Newswire | August 10, 2020

Did Hedge Funds Make The Right Call On ICU Medical, Inc. (ICUI) ?

How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies. However, an easier way is to look at the stocks that smart money investors are collectively bullish on. Hedge funds and other institutional investors usually invest large amounts of […]

Yahoo | July 20, 2020

ICU Medical, Inc. Announces Time of Second Quarter 2020 Earnings Conference Call

SAN CLEMENTE, Calif., July 15, 2020 -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion.

Yahoo | July 15, 2020

Read More 'ICUI' Stories Here

ICUI Price Returns

1-mo 4.39%
3-mo -1.99%
6-mo -5.46%
1-year 2.30%
3-year -10.50%
5-year 64.11%
YTD 0.99%
2019 -18.51%
2018 6.31%
2017 46.59%
2016 30.65%
2015 37.70%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.9262 seconds.